However, this does not explain why BRCA1 or BRCA2 mutations predispose so specifically to breast and ovarian cancer nor why BRCA1 or BRCA2 insufficiency can have profound effects on processes such as proliferation and differentiation. The gene discussed is BRCA1; the disease is ovarian carcinoma.